A20 In Vitro High Content Screening (HCS) Assay

CAT#: ITS-0123-YF3876
Target Cell Organism: Mouse
Target Cell Alternative Name: A-20
Target Cell Name: A20
Assay Type: High-throughput Screening, High Content Screening and Reporter Gene Assays
Assay Overview
This assay is to provide A20-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
A20
Target Cell Organism
Mouse
Target Cell Background
A20 [A-20] is a BALB/c B cell lymphoma line derived from a spontaneous reticulum cell neoplasm found in an old BALB/cAnN mouse. This cell line can be used in immunology research.
Target Cell Alternative Name
A-20
Related Diseases
Lymphoma
Research Area
Oncology
Assay Name
In Vitro High Content Screening (HCS) Assay
Assay Description
HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.
Assay Type
High-throughput Screening, High Content Screening and Reporter Gene Assays
For Research Use Only | Not For Clinical Use
Online Inquiry